Service de Médecine interne et Maladies Infectieuses, France; Service de Néphrologie-HTA, Dialyses, Transplantation Rénale, France.
Service de Médecine interne et Maladies Infectieuses, France.
Int J Infect Dis. 2020 Oct;99:421-427. doi: 10.1016/j.ijid.2020.08.022. Epub 2020 Aug 11.
The incidence of acute kidney injury (AKI) in infective endocarditis (IE), its risk factors and consequences on patient and renal survival remain debated.
Patients hospitalized for a first episode of IE (possible or definite according to modified Duke criteria) between 2013 and 2016 were included. The primary endpoint was to determine risk factors for early AKI (E-AKI) during the first week of management of IE.
A total of 276 patients were included: 220 (79.7%) had definite IE and 56 (20.3%) had possible IE. E-AKI occurred in 150 patients (53%). IE due to Staphylococcus aureus (OR 3.41; 95% CI 1.83-6.39; p<0.01), history of diabetes (OR 2.34; 95% CI 1.25-4.37; p<0.01), peripheral arterial disease (OR 2.59; 95% CI 1.07-6.23; p<0.05), immunological manifestations (OR 3.11; 95% CI 1.31-7.39; p=0.01), and use of norepinephrine (OR 3.44; 95% CI 1.72-7.02; p<0.01) were associated with E-AKI. In subgroup analysis, infectious disease consultation was associated with a lower risk of AKI at day 7 (OR 0.41; 95% CI 0.16-0.88; p=0.04). E-AKI was associated with 1-year mortality (OR 1.65; 95% CI 1.03-2.64; p=0.04) and chronic kidney disease progression (OR 2.23; 95% CI 1.30-3.82; p<0.01).
E-AKI is common in IE and often associated with non-modifiable variables. Multidisciplinary management should be mandatory, and awareness of AKI diagnosis and etiological explorations should be raised.
感染性心内膜炎(IE)患者急性肾损伤(AKI)的发生率、危险因素及其对患者和肾脏生存率的影响仍存在争议。
纳入 2013 年至 2016 年间因首次 IE 住院的患者(根据改良 Duke 标准,可能或确诊)。主要终点是确定 IE 治疗的第一周内早期 AKI(E-AKI)的危险因素。
共纳入 276 例患者:220 例(79.7%)为明确 IE,56 例(20.3%)为可能 IE。150 例(53%)患者发生 E-AKI。金黄色葡萄球菌(OR 3.41;95%CI 1.83-6.39;p<0.01)、糖尿病史(OR 2.34;95%CI 1.25-4.37;p<0.01)、外周动脉疾病(OR 2.59;95%CI 1.07-6.23;p<0.05)、免疫表现(OR 3.11;95%CI 1.31-7.39;p=0.01)和去甲肾上腺素的使用(OR 3.44;95%CI 1.72-7.02;p<0.01)与 E-AKI 相关。亚组分析显示,感染病会诊与第 7 天 AKI 风险降低相关(OR 0.41;95%CI 0.16-0.88;p=0.04)。E-AKI 与 1 年死亡率(OR 1.65;95%CI 1.03-2.64;p=0.04)和慢性肾脏病进展(OR 2.23;95%CI 1.30-3.82;p<0.01)相关。
E-AKI 在 IE 中很常见,且常与不可改变的变量相关。多学科管理应是强制性的,应提高对 AKI 诊断和病因探索的认识。